An antibody–drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer

Joan Jacob(Brown Foundation), Kendra S. Carmon(Brown Foundation)
British Journal of Cancer
February 9, 2023
Cited by 21


Related Papers